New Therapeutic Approaches to the Treatment of Dyslipidemia 2: LDL-C and Lp(a)
Dyslipidemia is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). There are abundant and unequivocal data to indicate that low-density lipoproteins (LDL) are a cause of ASCVD. Reduction of plasma low-density lipoprotein cholesterol (LDL-C) by medical therapy such as statin...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Korean Society of Lipid and Atherosclerosis
2023-01-01
|
| Seria: | Journal of Lipid and Atherosclerosis |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.1.37&code=9992JLA&vmode=FULL |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|